首頁 > 市場調查報告書 > 醫療設備

生技設備

市場調查報告書

商品編碼

1566148

細胞分選市場規模、佔有率、成長分析，按技術、按產品/服務、按應用、按地區 - 產業預測，2024-2031

Cell Sorting Market Size, Share, Growth Analysis, By Technology, By Product and Services, By Application, By Region - Industry Forecast 2024-2031

出版日期: 2024年10月03日 | 出版商:

SkyQuest | 英文 157 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

2022年全球細胞分選市場規模為2.6476億美元，從2023年的2.8332億美元成長到2031年的4.8717億美元，在預測期內（2024-2031年）預計複合年成長率為7%。

由於癌症、幹細胞、免疫學、藥物發現等領域的研究舉措不斷增加，全球細胞分選市場正在強勁成長。這種快速成長是由對了解細胞功能和疾病機制的日益成長的需求推動的，這對於標靶治療的開發至關重要。細胞分選技術在診斷、個人化治療和疾病管理中發揮重要作用。加上高速、高解析度串流細胞儀和創新分選演算法的進步，這些技術正在提高分選過程的效率、準確性和吞吐量。細胞成像和即時監測等功能的整合進一步推動了市場勢頭。儘管具有成長潛力，但該市場仍面臨挑戰，例如購買和維護細胞分選設備的高成本，這阻礙了其採用，特別是在資源有限的環境中。此外，細胞分選程序的複雜性需要熟練的操作員，而缺乏訓練有素的人員是更廣泛採用的障礙。此外，管理人體細胞使用的倫理和監管環境使營運框架變得複雜，並可能影響市場擴張。然而，由於持續的技術創新和在各個治療領域的廣泛應用，美國細胞分選市場預計在可預見的未來將保持穩定的複合年成長率。

市場概況
北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 義大利
- 其他歐洲國家地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 其他亞太地區
拉丁美洲
- 巴西
- 其他拉丁美洲地區
中東和非洲 (MEA)
- 海灣合作理事會國家
- 南非
- 其他中東/非洲地區

競爭格局

前5名企業對比
主要企業市場定位（2023年）
主要市場參與者所採取的策略
近期市集活動
主要企業市場佔有率（2023年）

主要企業簡介

Becton, Dickinson and Company
Beckman Coulter, Inc.
Bio-Rad Laboratories, Inc.
Sony
Miltenyi Biotec GmbH
Thermo Fisher Scientific
Merck KGaA
Sysmex Partec GmbH
On-Chip Biotechnologies Co., Ltd.
Cytonome/St, LLC
Union Biometrica, Inc.
BioLegend
Cytek Biosciences
Microsaic Systems
Sartorius AG
Verity Software House
STEMCELL Technologies
Cytognos SL
NanoCellect Biomedical, Inc.
Oxford Nanopore Technologies

簡介目錄

Product Code: SQMIG35A2354

Global Cell Sorting Market size was valued at USD 264.76 million in 2022 and is poised to grow from USD 283.32 million in 2023 to USD 487.17 million by 2031, growing at a CAGR of 7% during the forecast period (2024-2031).

The global cell sorting market is witnessing robust growth driven by heightened research initiatives in cancer, stem cell, immunology, and drug discovery. This surge stems from the increasing need to comprehend cellular functions and disease mechanisms, essential for developing targeted therapies. A significant factor amplifying demand is the rising incidence of chronic and infectious diseases, where cell sorting technology plays a critical role in diagnosis, treatment personalization, and disease management. Coupled with advancements in high-speed, high-resolution flow cytometers and innovative sorting algorithms, these technologies are enhancing the efficiency, accuracy, and throughput of sorting processes. The integration of features like cell imaging and real-time monitoring is further propelling market momentum. Despite its growth potential, the market faces challenges, including the high costs associated with purchasing and maintaining cell sorting equipment, which can impede adoption, particularly in resource-limited environments. Additionally, the complexity of cell sorting procedures necessitates skilled operators, and the scarcity of trained personnel poses a barrier to wider implementation. Furthermore, the ethical and regulatory landscape governing the use of human cells complicates the operational framework, potentially impacting market expansion. However, the U.S. cell sorting market is positioned to sustain a steady CAGR in the coming forecast period, driven by continuous innovation and increasing applications in various therapeutic areas.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Cell Sorting market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Cell Sorting Market Segmental Analysis

Global Cell Sorting Market is segmented by Technology, Product and Services, Application, End User, and Region. Based on Technology, the market is segmented into Fluorescence-Based Droplet Cell Sorting (Jet-In-Air Cell Sorting, Cuvette-Based Cell Sorting), Magnetic-Activated Cell Sorting (MACS), Micro-Electromechanical Systems (MEMS) - Microfluidics. Based on Product and Services, the market is segmented into Cell Sorters (High-Range Cell Sorters (Priced Above USD 300,000), Mid-Range Cell Sorters (Priced Between USD 200,000-USD 300,000), Low-Range Cell Sorters (Priced Below USD 200,000)), Cell Sorting Reagents And Consumables, Cell Sorting Services. Based on Application, the market is segmented into Research Applications (Immunology & Cancer Research, Stem Cell Research, Drug Discovery, Other Research Applications), Clinical Applications. Based on End User, the market is segmented into Research Institutions, Medical Schools And Academic Institutions, Pharmaceutical And Biotechnology Companies, Hospitals And Clinical Testing Laboratories. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Cell Sorting Market

The global cell sorting market is significantly driven by the increasing incidence of chronic diseases, including cancer, immunological disorders, and cardiovascular conditions. These diseases necessitate advanced diagnostic and therapeutic solutions, wherein cell sorting technologies play a vital role by enabling precise characterization and isolation of specific cell populations. This precision is critical for effective disease diagnosis, monitoring patient responses, and developing personalized treatment strategies. As healthcare systems worldwide prioritize improved patient outcomes and tailored therapies, the demand for sophisticated cell sorting techniques will continue to escalate, propelling the market's growth and innovation in cell-based research and therapeutic applications.

Restraints in the Global Cell Sorting Market

The Global Cell Sorting market faces a significant restraint due to the critical shortage of trained professionals equipped with the necessary skills and expertise to operate complex cell sorting technologies effectively. This scarcity not only impedes market growth but also poses challenges in data analysis and interpretation, which are crucial for achieving accurate and reliable results. As cell sorting techniques require specialized training to navigate their intricate methodologies, the inability to adequately train and retain skilled personnel may lead to slower adoption rates and limited utilization of these advanced technologies, ultimately constraining the market's development potential.

Market Trends of the Global Cell Sorting Market

The Global Cell Sorting market is witnessing a significant shift towards microfluidic-based cell sorting technologies, which are rapidly gaining traction due to their innovative approach to cell manipulation. By leveraging microscale channels, these systems enhance sorting accuracy and efficiency while minimizing sample and reagent usage. This trend is propelled by the increasing demand for precise sorting of rare cell types and the convenience offered by the compact, portable nature of microfluidic devices, making them ideal for point-of-care applications. As research and clinical needs evolve, microfluidic cell sorting is poised to dominate the market, driving advancements in diagnostics and therapeutics.

Introduction

Objectives of the Study
Definitions
Market Scope

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Market Overview Outlook
Supply Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers

Key Market Insights

Key Success Factor
Degree of Competition
Top Investment Pockets
Ecosystem of the Market
Technology Analysis
Regulatory Landscape
Patent Analysis

Cell Sorting Market, by Technology

Market Overview
Fluorescence-Based Droplet Cell Sorting
- Jet-In-Air Cell Sorting
- Cuvette-Based Cell Sorting
Magnetic-Activated Cell Sorting (MACS)
Micro-Electromechanical Systems (MEMS) - Microfluidics

Cell Sorting Market, by Product & Service

Market Overview
Cell Sorters
- High-Range Cell Sorters (Priced Above USD 300,000)
- Mid-Range Cell Sorters (Priced Between USD 200,000-USD 300,000)
- Low-Range Cell Sorters (Priced Below USD 200,000)
Cell Sorting Reagents And Consumables
Cell Sorting Services

Cell Sorting Market, by Application

Market Overview
Research Applications
- Immunology & Cancer Research
- Stem Cell Research
- Drug Discovery
- Other Research Applications
Clinical Applications

Cell Sorting Market, by End User

Market Overview
Research Institutions
Medical Schools And Academic Institutions
Pharmaceutical And Biotechnology Companies
Hospitals And Clinical Testing Laboratories

Cell Sorting Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2023
Strategies Adopted by Key Market Players
Recent Activities in the Market
Key Companies Market Share (%), 2023

Key Company Profiles

Becton, Dickinson and Company
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Beckman Coulter, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bio-Rad Laboratories, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sony
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Miltenyi Biotec GmbH
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Thermo Fisher Scientific
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merck KGaA
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sysmex Partec GmbH
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
On-Chip Biotechnologies Co., Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cytonome/St, LLC
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Union Biometrica, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BioLegend
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cytek Biosciences
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Microsaic Systems
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sartorius AG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Verity Software House
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
STEMCELL Technologies
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cytognos S.L.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
NanoCellect Biomedical, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Oxford Nanopore Technologies
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments